Fernando, Teresita C.
HRN: 21-07-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2023
CEFUROXIME 500MG (TAB)
07/23/2023
07/29/2023
ORAL
500mg
BID
Sp TAHBSO
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes